Wellington Management Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Sell |
34,018
-2,304
| -6% | -$21.9K | ﹤0.01% | 1848 |
|
|
2025
Q1 | $380K | Sell |
36,322
-2,228
| -6% | -$23.3K | ﹤0.01% | 1848 |
|
|
2024
Q4 | $908K | Sell |
38,550
-3,111
| -7% | -$73.3K | ﹤0.01% | 1718 |
|
|
2024
Q3 | $1.5M | Sell |
41,661
-184,761
| -82% | -$6.64M | ﹤0.01% | 1615 |
|
|
2024
Q2 | $7.99M | Sell |
226,422
-8,866
| -4% | -$313K | ﹤0.01% | 1214 |
|
|
2024
Q1 | $6.68M | Buy |
235,288
+89,814
| +62% | +$2.55M | ﹤0.01% | 1258 |
|
|
2023
Q4 | $1.93M | Buy |
145,474
+29,539
| +25% | +$393K | ﹤0.01% | 1502 |
|
|
2023
Q3 | $1.04M | Buy |
115,935
+5,371
| +5% | +$48.1K | ﹤0.01% | 1603 |
|
|
2023
Q2 | $1.24M | Buy |
110,564
+34,345
| +45% | +$386K | ﹤0.01% | 1570 |
|
|
2023
Q1 | $878K | Sell |
76,219
-1,821
| -2% | -$21K | ﹤0.01% | 1689 |
|
|
2022
Q4 | $904K | Sell |
78,040
-4,380
| -5% | -$50.8K | ﹤0.01% | 1655 |
|
|
2022
Q3 | $1.05M | Sell |
82,420
-12,693
| -13% | -$161K | ﹤0.01% | 1643 |
|
|
2022
Q2 | $653K | Hold |
95,113
| – | – | ﹤0.01% | 1761 |
|
|
2022
Q1 | $917K | Sell |
95,113
-1,667,940
| -95% | -$16.1M | ﹤0.01% | 1754 |
|
|
2021
Q4 | $21M | Sell |
1,763,053
-732,334
| -29% | -$8.71M | ﹤0.01% | 1062 |
|
|
2021
Q3 | $40.5M | Sell |
2,495,387
-1,512,045
| -38% | -$24.6M | 0.01% | 884 |
|
|
2021
Q2 | $84.3M | Buy |
4,007,432
+216,655
| +6% | +$4.56M | 0.01% | 679 |
|
|
2021
Q1 | $58.9M | Buy |
3,790,777
+886,055
| +31% | +$13.8M | 0.01% | 754 |
|
|
2020
Q4 | $60.3M | Buy |
2,904,722
+361,962
| +14% | +$7.52M | 0.01% | 711 |
|
|
2020
Q3 | $49.9M | Buy |
+2,542,760
| New | +$49.9M | 0.01% | 697 |
|